ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,531, issued on Aug. 5, was assigned to BIONTECH SE (Mainz, Germany).
"Use of RNA for reprogramming somatic cells" was invented by Ugur Sahin (Mainz, Germany), Marco Poleganov (Frankfurt, Germany) and Tim Beissert (Griesheim, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for effecting the de-differentiation of somatic cells to cells having stem cell characteristics, in particular pluripotency, include the steps of introducing RNA encoding factors inducing the de-differentiation of somatic cells into the somatic cells and culturing the somatic cells allowing the cells to de-differentiate."
The patent was filed on April 27, 2021, under...